Font Size: a A A
Keyword [NVAF]
Result: 1 - 20 | Page: 1 of 2
1. Retrospective Analysis Of The Influence Factors For Stroke In Patients With NVAF
2. The Risk Factor Analysis For Stroke In Non-valvular Atrial Fibrillation Patients With Low-intermediate Risk CHADS2Score
3. Correlation Between Left Atrial Size And Stroke Risk In Non Valvular Atrial Fibrillation (NVAF): A Clinical Research
4. Evaluation Of CHA2DS2-VASc Score For Short-term Prognosis Of Ischemic Stroke Caused By NVAF
5. A Meta-analysis Of The Effectiveness And Safety Of Different Antithrombotic Drugs In Anticoagulant Therapy For Atrial Fibrillation
6. Retrospective Study Of Rivaroxaban In Prevention Of Stroke In Non-vavular Atrial Fibrillation
7. Clinical Study Of Non-Valvular Atrial Fibrillation With Long R-R Interval
8. Epidemiological Investigation Of Patients With NVAF Complicated With ACS Undergoing PCI And A Long-term Follow-up Study Using Different Antithrombotic Regimens
9. The Influence Factors Of Atrial Thrombosis In Patients With NVAF And The Comparison Of Anticoagulant Effect
10. Investigation And Analysis Of The Application Situation Of Anticoagulant Durgs For Patients With Non-valvular Atrial Fibrillation In Our Hospital
11. Study On TDM Monitoring,Hemorrhage Risk And Thrombosis Risk Of Dabigatran Etexilate In NVAF Patients For Atrial Fibrillation Ablation In China
12. Study On The Effect Of New Oral Anticoagulant On Platelet Function And Coagulation Function In Patients With Atrial Fibrillation
13. Risk Factors For Ischemic Stroke In Patients With Non-Valvular Artial Fibrillation
14. Risk Factors Of Leukodystrophy In Patients With Nvaf And The Relationship Between B-type Diuretic Natriuretic Peptide,Cystatin C And Leukodystrophy
15. The influence of socioeconomic status on selection of anticoagulation for atrial fibrillation: A population based study
16. Clinical Follow-up Results And Analysis Of Patients With NVAF After Percutaneous Left Atrial Appendage Occlusion
17. Comparison Of The Application Of Antithrombotic Therapy Dabigatran Etexilate And Rivaroxaban In High Bleeding Risk Patients With ACS And NVAF Undering PCI
18. Study On The Correlation Between Deficiency And Solid Constitution And The Risk Of Thrombosis In Elderly Patients With NVAF
19. Efficacy Of Left Atrial Appendage Closure And Rivaroxaban Anticoagulation In The Prevention Of Stroke In Patients With NVAF
20. Serum Levels Of Gremlin-1 In Patients With NVAF Expression And Clinical Significance
  <<First  <Prev  Next>  Last>>  Jump to